These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab. Brunasso AM; Massone C Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830 [No Abstract] [Full Text] [Related]
8. Update on TNF Inhibitors in Dermatology. Sobell JM Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S104-6. PubMed ID: 27537073 [TBL] [Abstract][Full Text] [Related]
9. Anti-tumor necrosis factor (TNF)-induced lupus in a patient with hidradenitis suppurativa. Turk D; Vellaichamy G; Lyons AB; Parks-Miller A; Nelson T; Meysami A; Hamzavi IH Int J Dermatol; 2020 Mar; 59(3):e73-e74. PubMed ID: 31633193 [No Abstract] [Full Text] [Related]
10. Etanercept for the treatment of hidradenitis suppurativa. Sotiriou E; Apalla Z; Ioannidos D Acta Derm Venereol; 2009; 89(1):82-3. PubMed ID: 19197548 [No Abstract] [Full Text] [Related]
11. Moderate to severe hidradenitis suppurativa treated with biological therapies. Chinniah N; Cains GD Australas J Dermatol; 2014 May; 55(2):128-31. PubMed ID: 24456051 [TBL] [Abstract][Full Text] [Related]
12. Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa. Ann Intern Med; 2012 Dec; 157(12):I-50. PubMed ID: 23247950 [No Abstract] [Full Text] [Related]
13. Treatment of moderate to severe hidradenitis suppurativa. Kimball AB; Gu Y; Okun M Ann Intern Med; 2013 Jul; 159(1):72-3. PubMed ID: 23817710 [No Abstract] [Full Text] [Related]
14. Treatment of moderate to severe hidradenitis suppurativa. Prasad V Ann Intern Med; 2013 Jul; 159(1):72. PubMed ID: 23817709 [No Abstract] [Full Text] [Related]
15. Flexural or inverse psoriasis in a patient with hidradenitis suppurativa receiving treatment with infliximab. Nuño-González A; Dehesa L; Ricotti C; Kerdel F Actas Dermosifiliogr; 2012 Dec; 103(10):936-7. PubMed ID: 23149048 [No Abstract] [Full Text] [Related]
16. Sirolimus as combination rescue therapy with tumor necrosis alpha inhibitors for severe, refractory hidradenitis suppurativa. Bettuzzi T; Frumholtz L; Jachiet M; Lepelletier C; Djermane M; Cordoliani F; Saussine A; Bouaziz JD; Bachelez H J Am Acad Dermatol; 2020 Nov; 83(5):1441-1444. PubMed ID: 32565204 [No Abstract] [Full Text] [Related]
17. PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition. Saraceno R; Babino G; Chiricozzi A; Zangrilli A; Chimenti S J Am Acad Dermatol; 2015 Jan; 72(1):e42-4. PubMed ID: 25497954 [No Abstract] [Full Text] [Related]
18. Low prescription of tumor necrosis alpha inhibitors in hidradenitis suppurativa: A cross-sectional analysis. Orenstein LAV; Wright S; Strunk A; Garg A J Am Acad Dermatol; 2021 May; 84(5):1399-1401. PubMed ID: 32758630 [No Abstract] [Full Text] [Related]
19. Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience. Bettoli V; Manfredini M; Calamo G; Forconi R; Bencivelli D; Mantovani L; Pellacani G; Corazza M Dermatol Ther; 2018 Nov; 31(6):e12737. PubMed ID: 30295378 [No Abstract] [Full Text] [Related]
20. [Treatment options in severe hidradenitis suppurativa]. Mooij JE; van't Oost L; Leenarts MF; Mekkes JR Ned Tijdschr Geneeskd; 2011; 155():A1912. PubMed ID: 21426594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]